2012 full year EPS expected was .47 and actual was .61 for a .14 beat and they beat Q4 by .13 too. If that was headline would make a big difference. They have totally restructured the company and looks like they are in great shape for this year and beyond.
Does not look like they included any revenues from "emerging remote presence" business in 2013 projections and once they announce the 3D printer w/robot product that they filed for a patent the stock should really start to move.
This company is definitely set up for the long-haul massive adoption of robotics. Of course all this won't happen overnight, but the long-term IRBT holders should reward those with patients very well!! IMHO$$